• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Achieving Biologics manufacturing milestones using a systemic approach to Technology Transfer

Introduction

A poor technology transfer has many ramifications – problems with initial batches, analytical testing, packaging, and potentially, patient safety. Conversely, a successful technology transfer ensures that product quality does not suffer, while also saving time and resources.

This Point of View explains how Syngene, a leading global CRO/CDMO, has devised a systemic approach to achieving ‘100% first time right’ technology transfer in Biologics manufacturing. The methodology comprises a risk-based approach for assessing incoming data from the client-side. This involves assessing confidence levels for processes and analytical methods using a Decision Tree, arriving at risk mitigation strategies, and finally executing the transfer using a detailed Technology Transfer approach document to achieve ‘100% first time right’.

The methodology has resulted in a track record of consistent yield, regardless of differences in infrastructure, equipment, raw materials, processes, and more, between the client’s site and Syngene.

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details